Cargando…

A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology

We report the development of a deep learning algorithm (AI) to detect signs of diabetic retinopathy (DR) from fundus images. For this, we use a ResNet-50 neural network with a double resolution, the addition of Squeeze–Excitation blocks, pre-trained in ImageNet, and trained for 50 epochs using the A...

Descripción completa

Detalles Bibliográficos
Autores principales: Pareja-Ríos, Alicia, Ceruso, Sabato, Romero-Aroca, Pedro, Bonaque-González, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456446/
https://www.ncbi.nlm.nih.gov/pubmed/36078875
http://dx.doi.org/10.3390/jcm11174945
_version_ 1784785817559891968
author Pareja-Ríos, Alicia
Ceruso, Sabato
Romero-Aroca, Pedro
Bonaque-González, Sergio
author_facet Pareja-Ríos, Alicia
Ceruso, Sabato
Romero-Aroca, Pedro
Bonaque-González, Sergio
author_sort Pareja-Ríos, Alicia
collection PubMed
description We report the development of a deep learning algorithm (AI) to detect signs of diabetic retinopathy (DR) from fundus images. For this, we use a ResNet-50 neural network with a double resolution, the addition of Squeeze–Excitation blocks, pre-trained in ImageNet, and trained for 50 epochs using the Adam optimizer. The AI-based algorithm not only classifies an image as pathological or not but also detects and highlights those signs that allow DR to be identified. For development, we have used a database of about half a million images classified in a real clinical environment by family doctors (FDs), ophthalmologists, or both. The AI was able to detect more than 95% of cases worse than mild DR and had 70% fewer misclassifications of healthy cases than FDs. In addition, the AI was able to detect DR signs in 1258 patients before they were detected by FDs, representing 7.9% of the total number of DR patients detected by the FDs. These results suggest that AI is at least comparable to the evaluation of FDs. We suggest that it may be useful to use signaling tools such as an aid to diagnosis rather than an AI as a stand-alone tool.
format Online
Article
Text
id pubmed-9456446
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94564462022-09-09 A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology Pareja-Ríos, Alicia Ceruso, Sabato Romero-Aroca, Pedro Bonaque-González, Sergio J Clin Med Article We report the development of a deep learning algorithm (AI) to detect signs of diabetic retinopathy (DR) from fundus images. For this, we use a ResNet-50 neural network with a double resolution, the addition of Squeeze–Excitation blocks, pre-trained in ImageNet, and trained for 50 epochs using the Adam optimizer. The AI-based algorithm not only classifies an image as pathological or not but also detects and highlights those signs that allow DR to be identified. For development, we have used a database of about half a million images classified in a real clinical environment by family doctors (FDs), ophthalmologists, or both. The AI was able to detect more than 95% of cases worse than mild DR and had 70% fewer misclassifications of healthy cases than FDs. In addition, the AI was able to detect DR signs in 1258 patients before they were detected by FDs, representing 7.9% of the total number of DR patients detected by the FDs. These results suggest that AI is at least comparable to the evaluation of FDs. We suggest that it may be useful to use signaling tools such as an aid to diagnosis rather than an AI as a stand-alone tool. MDPI 2022-08-23 /pmc/articles/PMC9456446/ /pubmed/36078875 http://dx.doi.org/10.3390/jcm11174945 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pareja-Ríos, Alicia
Ceruso, Sabato
Romero-Aroca, Pedro
Bonaque-González, Sergio
A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology
title A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology
title_full A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology
title_fullStr A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology
title_full_unstemmed A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology
title_short A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology
title_sort new deep learning algorithm with activation mapping for diabetic retinopathy: backtesting after 10 years of tele-ophthalmology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456446/
https://www.ncbi.nlm.nih.gov/pubmed/36078875
http://dx.doi.org/10.3390/jcm11174945
work_keys_str_mv AT parejariosalicia anewdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology
AT cerusosabato anewdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology
AT romeroarocapedro anewdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology
AT bonaquegonzalezsergio anewdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology
AT parejariosalicia newdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology
AT cerusosabato newdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology
AT romeroarocapedro newdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology
AT bonaquegonzalezsergio newdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology